|January 28, 2019
AMA Outlines Policy Proposals to Combat Prescription Drug Price Increases
[from the AMA Advocacy Update]
In an ongoing effort to increase drug price transparency and address the rising cost of prescription drugs, the AMA has released a two-page advocacy document "Improving Prescription Drug Price and Cost Transparency" which outlines specific policy proposals aimed at each of the key players involved in drug pricing: pharmaceutical companies, pharmacy benefit managers (PBMs) and health insurers. All these groups contribute to prescription drug cost increases that influence patient cost-sharing, prior authorization policies and patient adherence to treatment plans, which ultimately impact patient health status and outcomes.
< Previous Article | Next Article >
[ return to top ]
ensure delivery of Maine Medicine Weekly Update,
please add 'firstname.lastname@example.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm
For more information or to contact us directly, please visit www.mainemed.com | ©